Last update 23 Nov 2024

HLX-55

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
HLX 55, KTN-0216, KTN0216
Target
c-Met
Mechanism
c-Met inhibitors(Hepatocyte growth factor receptor inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases+ [2]
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmGlioblastomaLiver Cancer+ [2]
Originator Organization
Kolltan Pharmaceuticals, Inc.Kolltan Pharmaceuticals, Inc.
Active Organization-
Inactive Organization
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Henlix, Inc.Henlix, Inc.Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HLX-55
NCT04169178 / Unknown statusPhase 1
A Phase 1 Dose Finding/Expansion Study of HLX55, A Monoclonal Antibody Targeting Tyrosine-Protein Kinase MET (C-MET) in Patients With Advanced Solide Tumors Refactory to Standard Therapy
100 Clinical Results associated with HLX-55
Login to view more data
100 Translational Medicine associated with HLX-55
Login to view more data
100 Patents (Medical) associated with HLX-55
Login to view more data
100 Deals associated with HLX-55
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
TW
Henlix, Inc.Henlix, Inc.
03 Mar 2020
Liver CancerIND Approval
CN
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
10 Aug 2019
Lung CancerIND Approval
CN
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
10 Aug 2019
Stomach CancerIND Approval
CN
Shanghai Henlius Biotech, Inc.Shanghai Henlius Biotech, Inc.
10 Aug 2019
GlioblastomaPreclinical
CN
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
13 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free